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Abstract
This study tested the hypothesis that human macrophages have the ability to modify oxidation
products in LDL and oxidized LDL (oxLDL) via a cellular antioxidant defence system. While many
studies have focused on macrophage LDL oxidation in atherosclerosis development, less attention
has been given to the cellular antioxidant capacity of these cells.
Compared to cell-free controls (6.2 ± 0.7 nmol/mg LDL), macrophages reduced TBARS to 4.42 ±
0.4 nmol/mg LDL after 24 h incubation with LDL (P = 0.022). After 2 h incubation with oxLDL,
TBARS were 3.69 ± 0.5 nmol/mg LDL in cell-free media, and 2.48 ± 0.9 nmol/mg LDL in the
presence of macrophages (P = 0.034). A reduction of lipid peroxides in LDL (33.7 ± 6.6 nmol/mg
LDL) was found in the presence of cells after 24 h compared to cell-free incubation (105.0 ± 14.1
nmol/mg LDL) (P = 0.005). The levels of lipid peroxides in oxLDL were 137.9 ± 59.9 nmol/mg LDL
and in cell-free media 242 ± 60.0 nmol/mg LDL (P = 0.012). Similar results were obtained for
hydrogen peroxide. Reactive oxygen species were detected in LDL, acetylated LDL, and oxLDL by
isoluminol-enhanced chemiluminescence (CL). Interestingly, oxLDL alone gives a high CL signal.
Macrophages reduced the CL response in oxLDL by 45% (P = 0.0016). The increased levels of
glutathione in oxLDL-treated macrophages were accompanied by enhanced catalase and
glutathione peroxidase activities.
Our results suggest that macrophages respond to oxidative stress by endogenous antioxidant
activity, which is sufficient to decrease reactive oxygen species both in LDL and oxLDL. This may
suggest that the antioxidant activity is insufficient during atherosclerosis development. Thus,
macrophages may play a dual role in atherogenesis, i.e. both by promoting and limiting LDL-
oxidation.
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Introduction
Oxidative modification of low density lipoprotein (LDL)
plays a major role in the pathogenesis of atherosclerosis.
The first stage of atherogenesis is characterized by an
influx and accumulation of LDL in the intima, followed
by recruitment of blood-derived monocytes and lym-
phocytes to the developing lesion [1]. Subsequently, LDL
is oxidatively modified by free radicals that are either
secreted from cells within lesions or generated extracellu-
lar in the arterial wall [2]. Oxidatively modified LDL
(oxLDL) induces a multitude of cellular responses which
lead to vascular dysfunction [3]. Much attention has sofar
been devoted to the mechanisms by which cells oxidize
LDL, since interventions targeting these mechanisms
could prevent or retard the disease process.
However, cells may also provide a protective effect by
reducing oxidation products present in LDL and oxLDL.
Murine macrophages effectively block LDL oxidation by
mechanisms which include metal ion sequestration [4].
Recent studies show that macrophages decrease choles-
teryl ester hydroperoxide levels in LDL, an antioxidant
action that is proportional to cell number [5,6]. In addi-
tion, endothelial cells prevent accumulation of lipid
hydroperoxides in LDL [7]. Human hepatic cells show a
protective role by selective uptake and detoxification of
cholesterol ester hydroperoxides present in high density
lipoprotein [8]. Enzymes associated with antioxidant
defense, such as manganese superoxide dismutases, cata-
lase, and glutathione peroxidases are induced by oxidants
in vitro [9-11].
Four selenium-dependent glutathione peroxidases (GPx)
have been identified sofar: cytosolic GPx (cGPx), gastroin-
testinal GPx (GI-GPx), plasma GPx (pGPx), and phos-
pholipid hydroperoxide GPx (PHGPx) [12,13]. The
PHGPx reduces hydroperoxides present in complex lipids
such as phospholipids and cholesteryl esters [14,15].
Interestingly, increased glutathione levels are present in
macrophages derived from the human monocytic cell line
THP-1, as well as in mouse peritoneal macrophages after
incubation with oxLDL [16,17]. An increased activity of
both glutathione peroxidase and superoxide dismutase
occurs in the arterial wall of cholesterol-fed rabbits [18].
Furthermore, lipid-laden macrophages within atheroscle-
rotic vessels express an extracellular form of superoxide
dismutase (EC-SOD) [19].
This study tested the hypothesis that human macrophages
have the ability to modify oxidation products in LDL and
oxLDL. We also analyzed the activity of cellular antioxi-
dant defenses such as catalase, glutathione peroxidase,
and superoxide dismutase in these cells. We used early
macrophages as cell culture model to mimic newly
recruited macrophages into the intima.
Materials and methods
Cell isolation
Mononuclear cells were isolated by the Ficoll-Hypaque
procedure (Pharmacia, Uppsala, Sweden) [20] from buffy
coats obtained from the blood of healthy donors from the
Blood Bank at Sahlgrenska University Hospital, Göteborg.
Monocytes in RPMI 1640 medium (Life Technologies,
Paisley, Scotland), supplemented with non-essential
amino acids, 2 mM sodium pyruvate, 100 U/mL penicil-
lin, and 100 µg/mL streptomycin were seeded in 6 well
plates at 4 × 106 cells per well. Non-adherent cells were
removed after 1 h. RPMI 1640 containing 100 µg/mL LDL
or oxLDL was incubated at 37°C in 5% CO2 in the pres-
ence or absence of macrophages. By definition, mono-
cytes are denoted macrophages when they are attached,
thus the cells used in this study are considered early
human monocyte-derived macrophages (HMDM).
For chemiluminescence experiments, monocytes were
allowed to adhere to cell culture flasks for 1 h. Adhered
macrophages were then detached by incubation with PBS
containing 5 mM EDTA and 2% fetal calf serum for 20
minutes at +4°C [21]. Cells were collected, washed, and
resuspended to a density of 5 × 106 cells/mL in Krebs-
Ringer Bicarbonate buffer supplemented with glucose
(KRG) (Sigma, St. Louis, Missouri). To obtain non-viable
macrophages, cells were stored at +4°C for 16 h. Trypan
blue exclusion test confirmed that 100% of the cells were
non-viable.
Lipoproteins
Fresh human EDTA-plasma was obtained from healthy
male donors after overnight fasting. LDL (density 1.019–
1.063 g/L) was isolated by sequential ultracentrifugation
[22]. Before oxidation, native LDL was desalted on a PD-
10 column equilibrated with PBS containing 100 µg/mL
penicillin and 100 µg/ml streptomycin (PEST) using PBS-
PEST as elution buffer. The LDL was oxidized at 37°C for
2–24 hours by 12.5 µmol CuSO4/mg LDL. Oxidation was
terminated through the addition of 0.5 mmol/L EDTA.
The oxLDL was purified on a PD-10 column with PBS as
elution buffer and sterilized by filtration through a 0.22
µm filter. Native LDL was acetylated as described [23].
Oxidation of LDL was determined as the relative electro-
phoretic mobility (REM), i.e. the ratio between the dis-
tance oxLDL and native LDL migrate on a 0.5% agarose
gel. The LDL in this study was oxidized for 2 h and had a
REM ranging from 1.06 to 1.32 and TBARS values
between 3 and 8 nmol MDA/mg LDL protein. Lipoprotein
concentrations were determined with the BioRad protein
assay using γ -globulin as standard.
Chemiluminescence
The chemiluminescence (CL) assay was performed at
37°C and the CL detected for at least 100 minutes with aLipids in Health and Disease 2005, 4:6 http://www.lipidworld.com/content/4/1/6
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luminescence counter (Bio Orbit Luminometer 1251,
Turku, Finland) [21]. The CL response was detected in a
total volume of 1.0 mL, containing 10 µg isoluminol
(Sigma), 4 U horseradish peroxidase (Roche AB, Stock-
holm, Sweden), and 100 µg of either LDL, oxLDL, or
acLDL in KRG in the presence or absence of 5 × 105 cells.
As a specific inhibitor of hydrogen peroxide, 30 µg cata-
lase (Roche AB) was added in some experiments to oxLDL
without cells.
Measurement of oxidation products
Thiobarbituric acid-reactive substances (TBARS) were
determined by the method of Yagi [24]. Fluorescence was
measured at 553 nm with 515 nm excitation. Lipid perox-
ides (LPO) were determined by the Lipohydrox assay
from Wak-Chemie Medical (Bad-Soden, Germany). Lipid
peroxides are reduced to hydroxyl derivatives in the pres-
ence of hemoglobin, and the chromogen 10-N-methylcar-
bamyl-3, 7-dimethylamino-10H-phentiazine is
oxidatively cleaved to form methylene blue. Lipid perox-
ides are quantitated by colorimetric measuring of the
methylene blue at 675 nm.
Levels of hydrogen peroxide equivalents (H2O2eq) were
analyzed in the LDL-containing media incubated with or
without macrophages. The assay is based on the oxidation
of ferrous ions to ferric ions by hydrogen peroxide at
acidic pH (OXIS International Inc., Portland, Oregon).
The ferric ion binds to the indicator dye xylenol-orange to
form a stable complex which is measured at 560 nm.
Apolipoprotein B (Apo B) concentration was determined
in cell culture media by immunoprecipitation enhanced
by polyethylene glycol at 340 nm (Thermo Clinical Lab-
systems, Espoo, Finland). ApoB analyses were performed
on a Konelab 20 autoanalyser (Thermo Clinical
Labsystems).
Analysis of antioxidant properties of macrophages
The intracellular levels of glutathione and the activity of
GPx were measured in crude extracts from macrophages
incubated with either LDL or oxLDL. The cells were
washed twice with ice-cold PBS and harvested in 0.5 mL
lysis buffer. For glutathione peroxidase measurements,
this buffer contained 50 mM Tris-HCl, pH 7.5, 5 mM
EDTA, 1 mM dithiothreitol. For glutathione measure-
ments, the cells were lysed in 0.5 mL ice-cold 5% meta-
phosphoric acid. The lysate was spun down at 3000 × g,
and the supernatants stored at -80°C.
The presence of glutathione peroxidase was determined
with a colorimetric assay (Bioxytech GPX-340) and glu-
tathione (GSH) was measured with Bioxytech GSH-400,
both from OXIS International Inc. The assay GPX-340
measures the functional activity of the GPx. In functional
terms, all four types of GPx (cGPx, GI-GPx, pGPx, and
PHGPx) appear similar in catalytic activity [12,25].
ROOH + 2GSH ----GPx----> ROH + GSSG(oxidized glutath-
ione)+ H2O
GSSG + NADPH+ + H+ --------> 2GSH + NADP+
Catalase activity in macrophages was quantified by the
method of Aebi [26]. Decomposition of H2O2 was meas-
ured in cell lysates at 240 nm. One unit of catalase activity
was defined as the rate constant for the reaction using
purified catalase (Roche AB) as standard.
In the cell lysates, the CuZn-superoxide dismutase (SOD)
and Mn-SOD enzymatic activities were measured with a
direct spectrophotometric method [27]. Extracellular
SOD protein was determined by ELISA essentially as pre-
viously described [28].
Data analyses
Data were expressed as means ± standard error. Statistical
analysis was performed using Student's paired t-test or
ANOVA. P values < 0.05 were considered statistically
significant.
Results
Macrophages diminish oxidation products in LDL and 
oxLDL
To study the effect of macrophages on LDL oxidation, we
measured TBARS, LPO, and H2O2 in LDL-containing cul-
ture media after 2 h and 24 h incubation with or without
macrophages.
Compared to cell-free controls (6.2 ± 0.7 nmol/mg LDL),
there was a significant reduction of TBARS by macro-
phages to 4.42 ± 0.4 nmol/mg LDL after 24 h incubation
with LDL (P = 0.022) (Fig. 1A). After 2 h incubation with
oxLDL, TBARS was 3.69 ± 0.5 nmol/mg LDL in cell free
media, and 2.48 ± 0.9 nmol/mg LDL in the presence of
macrophages (P = 0.034). Although a time-dependent
increase of TBARS in the presence of cells is seen, this
change was not statistically significant. Lipid peroxide lev-
els are unaffected in LDL and oxLDL incubated in cell-free
wells during 2 h to 24 h (Fig. 1B). In the presence of cells,
a reduction of lipid peroxides in LDL (33.7 ± 6.6 nmol/mg
LDL) was found after 24 h compared to cell-free incuba-
tion (105.0 ± 14.1 nmol/mg LDL) (P = 0.005). In oxLDL,
the cell-mediated loss of lipid peroxides was significant
compared to cell-free media after 24 h. The levels of lipid
peroxides in oxLDL were 137.9 ± 59.9 nmol/mg LDL and
in cell-free media 242 ± 60.0 nmol/mg LDL (P = 0.012).
In LDL-containing media incubated in cell-free wells, the
levels of H2O2eq increase with time from 116 ± 31 nmol/
mg LDL after 2 h, to 270 ± 46 nmol/mg LDL after 24 h (PLipids in Health and Disease 2005, 4:6 http://www.lipidworld.com/content/4/1/6
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= 0.009) (Fig. 1C). Levels of H2O2eq increase from 303 ±
14 nmol/mg LDL to 357 ± 24 nmol/mg LDL in oxLDL-
containing media (P = 0.011), suggesting both LDL and
oxLDL are oxidized during culture conditions. H2O2eq is
significantly decreased in both LDL (P = 0.038) and
oxLDL (P = 0.035) after incubation with macrophages. In
macrophage-treated LDL, the H2O2eqcontent is decreased
to 14.8 ± 2.9 nmol/mg LDL after 24 h, which is similar to
levels found in non-treated LDL (0 h). Taken together,
these results suggest a cell-mediated loss of oxidation
products in both LDL and oxLDL in the presence of
macrophages.
Apo B was analysed to study if the cell mediated decrease
in oxidation products was due to a decrease of LDL or
oxLDL in the cell culture media. In the presence of macro-
phages, the content of apo B in native LDL is reduced by
7 % after 2 h (P = 0.013) and 11 % after 24 h (P = 0.025)
(Fig. 1D). In the oxLDL medium, no significant change of
apo B in the medium is found after 2 h, and the content
of apo B in oxLDL decreases 18% after 24 h incubation
with macrophages compared to cell-free control (P =
0.006). This result suggests that the decrease in oxidation
products can not be fully explained by an increased
uptake of LDL or oxLDL by macrophages.
To further test the capacity of macrophages to decrease
oxidation products in LDL, we used isoluminol-enhanced
chemiluminescence to detect reactive oxygen species in
LDL. OxLDL, acLDL, or LDL was incubated with macro-
phages (5 × 105cells) or without cells at 37°C. OxLDL
alone had a CL response of approximately 400 mV after 2
h (Fig. 2). AcLDL shows a low but increasing CL up to 30
mV after 2 h as does native LDL, but the response is lower
than that of oxLDL. In repeated experiments, incubation
of macrophages with oxLDL leads to a significant
Effect of macrophages on oxidation products in LDL and oxLDL Figure 1
Effect of macrophages on oxidation products in LDL and oxLDL. RPMI 1640 containing 100 µg/mL of LDL or oxLDL 
(oxidized for 2 h) was incubated in cell culture wells at 37°C with and without macrophages (HMDM) for 2 h and 24 h. Values 
are expressed as nmol/mg LDL, TBARS (n = 5) (A), lipid peroxides (n = 6) (B), H2O2 (n = 6), (C). Values of Apo B are 
expressed as % change compared to cell free control incubations (n = 4) (D).Lipids in Health and Disease 2005, 4:6 http://www.lipidworld.com/content/4/1/6
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reduction in the maximum peak value to 260 ± 45 mV
compared to 462 ± 127 mV for oxLDL alone (P < 0.01) (n
= 6). Adding catalase to oxLDL leads to a decrease of the
CL signal by 37%, suggesting peroxides in the oxLDL.
LDL oxidized by Cu2+ for 2, 8, or 20 h, shows similar max-
imum peak values, however a lag time of 10 min is
observed with the shorter oxidation times. Incubation of
oxLDL with macrophages leads to a reduction in the CL
signal (Fig. 3). Different dilutions of oxLDL lead to a dose
dependent increase in CL (Fig. 4). The addition of macro-
phages results in a 45% lower CL maximal peak value at
the different concentrations of oxLDL (P = 0.0016).
To exclude the possibility that quenching contributes to
the macrophage effect, oxLDL was incubated with non-
viable macrophages. No reduction in CL signal is seen
(Fig. 5), which suggests that no quenching occurred and
that viable cells are necessary for antioxidative activity.
LDL affects cellular antioxidant defences in macrophages
Since the levels of peroxides are elevated in oxLDL com-
pared to LDL, and the cellular defences against peroxides
excess are catalase and GPx, we investigated the cellular
activity of these enzymes in macrophages. Macrophages
incubated with oxLDL for 2 h have increased intracellular
activity of catalase (P = 0.006) and GPx (P = 0.0002) (Figs
6A and 6B). In contrast, no significant increase of the
intracellular activity of these enzymes occurs in macro-
phages incubated with LDL. In addition, the expression of
glutathione, which is a cofactor for the GPx enzymes
when H2O2 is detoxified, is enhanced in macrophages
treated with oxLDL for 2 h (P = 0.0048) (Fig. 6C).
Neither LDL nor oxLDL significantly affect the CuZn-SOD
or Mn-SOD activity in macrophages (Table I). However,
the Mn-SOD activity is enhanced after 24 h compared to
2 h incubations. Although an increase in secreted EC-SOD
is seen at 24 h, this change was not statistically significant.
Neither LDL nor oxLDL affect this secretion. These obser-
vations suggest that macrophages respond to oxLDL by
increasing their enzyme activity of catalase and glutath-
ione peroxidase.
Discussion
Oxidation of LDL is a crucial event in the pathophysiology
of atherosclerosis. Reactive oxygen species such as H2O2
participate in the oxidation of LDL [29]. Although the
Production of reactive oxygen species from LDL, oxLDL and macrophages as measured by isoluminol-enhanced  chemiluminescence Figure 2
Production of reactive oxygen species from LDL, oxLDL and macrophages as measured by isoluminol-
enhanced chemiluminescence. The incubation mixture of 1.0 mL KRG contained 5 × 105 cells (HMDM), 10 µg isoluminol, 
4 U horseradish peroxidase, and 100 µg of LDL, oxLDL (oxidized for 2 h), or acLDL. The chemiluminescence was measured 
every 2 minutes for a total of 100 minutes at 37°C (n = 5).Lipids in Health and Disease 2005, 4:6 http://www.lipidworld.com/content/4/1/6
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mechanisms are not fully understood, aortic cells such as
endothelial cells, smooth muscle cells, and macrophages
have the capacity to oxidize LDL in vitro. We have recently
shown that hypoxia enhances both macrophage-medi-
ated LDL oxidation and the expression of the putative
LDL-oxidizing enzyme 15-lipoxygenase-2 [30]. While
many studies have focused on cellular oxidation of LDL,
less attention has been given to the cellular antioxidant
capacity of macrophages.
This study shows that macrophages play an important
role in limiting lipid oxidation products that accumulate
in LDL and oxLDL. Since early macrophages are used in
this study, this may resemble newly recruited macro-
phages entering into the arterial intima. Regarding oxLDL,
macrophages decrease TBARS levels by about 30%, LPO
decreases 43%, and the H2O2eqcontent decreases 64% in
cell culture media after 24 h compared to cell-free con-
trols. These results are in agreement with an earlier study
where human macrophages reduce the content of choles-
teryl ester hydroperoxides in LDL by 43% [5]. When the
apo B content was analyzed in the culture media, we
found that the levels of apo B in oxLDL were 18% reduced
after 24 h incubation with macrophages compared to cell
free control. For LDL the corresponding figure was 11%,
which implies that the decrease in oxidation products can-
not be entirely explained by a higher uptake of LDL or
oxLDL by macrophages. Our results suggest that macro-
phages respond to oxidative stress by an endogenous anti-
oxidative activity, which is sufficient to decrease reactive
oxygen species; i.e. TBARS, LPO and H2O2 both in LDL
and oxLDL. Our data also suggest that oxidation products
accumulate in LDL and in oxLDL during regular cell cul-
ture conditions in the absence of cells. This has to be taken
into consideration when cell culture data using LDL are
interpreted.
The chemiluminescence technique is generally used to
detect cellular ROS production. The amplifying molecule
isoluminol reacts with ROS to produce an excited state
intermediate that emits light upon relaxation to the
ground state [31]. Our data show that oxLDL contains
reactive oxygen metabolites that have the capacity to
induce CL. Lipid hydroperoxides, the major oxidizing spe-
cies in oxLDL, are likely to cause the CL. In the presence of
transition metal ions, they generate Fenton-type oxidants,
which may induce the chemiluminescence. The CL
response is reduced when LDL is oxidized longer than 24
h. This agrees with previous data concerning the kinetics
of LDL oxidation where lipid hydroperoxides are formed
Production of reactive oxygen species from oxLDL and macrophages as measured by isoluminol-enhanced chemiluminescence Figure 3
Production of reactive oxygen species from oxLDL and macrophages as measured by isoluminol-enhanced 
chemiluminescence. The incubation mixture of 1.0 mL KRG, containing 10 µg isoluminol, 4 U horseradish peroxidase, and 
100 µg of oxLDL (oxidized for either 2 h, 8 h or 20 h), was used alone or in combination with 5 × 105 macrophages (HMDM) 
(n = 3).Lipids in Health and Disease 2005, 4:6 http://www.lipidworld.com/content/4/1/6
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during the propagation phase and are decreased during
the decomposition phase [32]. In the presence of macro-
phages, the CL response in oxLDL is reduced by 45%,
which suggests that these cells exhibit antioxidant activity.
Our results further suggest that cellular viability is neces-
sary for antioxidant activity.
There are a number of cellular defences against oxidative
stress, such as superoxide dismutase, catalase, and
glutathione-related enzymes. In this study we sought to
define the antioxidative activity of macrophages. All glu-
tathione peroxidases reduce H2O2 or soluble alkyl perox-
ides, by coupling its reduction of H2O with oxidation of
glutathione [11]. We found increased glutathione peroxi-
dase activity that coincided with enhanced glutathione
levels in oxLDL-treated macrophages. Only PHGPx
reduces hydroperoxy groups of lipids together with those
of phospholipids and cholesteryl esters when present in
lipoproteins [15]. Interestingly, overexpression of PHGPx
inhibits H2O2-induced oxidation and activation of NFκ B
in transfected rabbit smooth muscle cells [33]. Our results
may have in vivo relevance, since an increased activity of
glutathione peroxidase is found in the artery wall of cho-
lesterol-fed rabbits [18].
Catalase is a representative antioxidant enzyme and previ-
ous studies show that oxidants such as H2O2 and lipid per-
oxides induce catalase gene expression in cultured rabbit
endothelial cells, rabbit macrophages, and human
smooth muscle cells [10]. This study provides further
Dose-response effect of oxLDL on production of reactive oxygen species as measured by isoluminol-enhanced  chemiluminescence Figure 4
Dose-response effect of oxLDL on production of reactive oxygen species as measured by isoluminol-enhanced 
chemiluminescence. The incubation mixture of 1.0 ml KRG contained 10 µg isoluminol, and different concentrations of 
oxLDL oxidized for 2 h, alone and in combination with HMDM (5 × 105 cells). Data are shown as means of maximal peak values 
in mV ± SE for triplicate determinations within a single experiment and are representative of two independent experiments. 
Results of oxLDL in cell-free incubations versus oxLDL in the presence of macrophages were analyzed by ANOVA.Lipids in Health and Disease 2005, 4:6 http://www.lipidworld.com/content/4/1/6
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evidence that lipid hydroperoxides in oxLDL induce anti-
oxidant defences in macrophages, since human macro-
phages also upregulated their catalase activity. Human
macrophages induce catalase activity in response to oxida-
tive stress [34]. Addition of catalase to oxLDL alone
reduced the CL response by 37%, suggesting that perox-
ides are detected by the CL technique.
EC-SOD occurs in high concentration in both non-dis-
eased [35] and atherosclerotic arterial walls [19]. In non-
diseased arteries, the enzyme is primarily secreted by
smooth muscle cells, whereas in atherosclerotic lesions it
is also expressed by macrophages [19]. Higher levels of
EC-SOD are present in cell culture media after 24 h than
after 2 h, but the presence of LDL or oxLDL does not effect
EC-SOD expression. Similar results of EC-SOD expression
have been described in human fibroblasts [36]. The
expression of CuZn-SOD is neither affected by LDL,
oxLDL nor time. This was not unexpected since CuZn-
SOD is generally regarded as a constitutively expressed
enzyme. Mn-SOD activity increases with time, but there is
no additive effect of LDL or oxLDL on its activity.
Cells can tolerate mild oxidative stress, which triggers the
antioxidant defence system in an attempt to restore the
oxidant- antioxidant balance [37]. We did not find an
increase in antioxidant enzyme activity in LDL-treated
macrophages, which suggests that the basal levels of cata-
lase and GPx activity are sufficient to remove the oxida-
tion products in LDL. In contrast, the augmented catalase
and GPx activity suggests that oxLDL induces cellular
adaptation when macrophages are exposed to increased
oxidative stress.
This study suggests that oxidative stress induced by oxLDL
could be balanced by a cellular antioxidant defence by
newly recruited macrophages to sites of LDL oxidation. As
oxidation of LDL is implicated in the development of
atherosclerosis, and oxidation products of LDL are present
in advanced atheromatous lesions, this may suggest that
Production of reactive oxygen species from oxLDL and non-viable macrophages as measured by isoluminol-enhanced  chemiluminescence Figure 5
Production of reactive oxygen species from oxLDL and non-viable macrophages as measured by isoluminol-
enhanced chemiluminescence. The incubation mixture of 1.0 mL KRG, containing 10 µg isoluminol, 4 U horseradish per-
oxidase, and 100 µg of oxLDL (oxidized for 2 h), was used alone or in combination with 5 × 105 non-viable macrophages. Data 
are shown from a typical experiment with 2 different cell donors.Lipids in Health and Disease 2005, 4:6 http://www.lipidworld.com/content/4/1/6
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Effect of LDL and oxLDL on the intracellular antioxidant defenses in macrophages Figure 6
Effect of LDL and oxLDL on the intracellular antioxidant defenses in macrophages. The intracellular activity of cat-
alase (A), glutathione peroxidase (B), and the levels of glutathione (C) were measured in crude extracts from macrophages (n 
= 6) incubated with LDL or oxLDL (oxidized for 2 h). Control cells were incubated in the absence of LDL. Results were ana-
lyzed by ANOVA.Lipids in Health and Disease 2005, 4:6 http://www.lipidworld.com/content/4/1/6
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the antioxidant activity is insufficient in vivo. Thus, it is
evident that macrophages play a dual role in atherogene-
sis, i.e. both by promoting and limiting LDL-oxidation. It
remains to be determined during which stage of lesion
development these individual characteristics pertain.
A strategy to intervene with the development of athero-
sclerosis would be to increase the endogenous intracellu-
lar antioxidant capacity of cells, which would remove and
detoxify oxidized LDL. Interestingly, recent results show
that Lovastatin increases hepatic catalase activity in cho-
lesterol-fed rabbits [38]. In light of the response-to-reten-
tion hypothesis of atherosclerosis, subendothelial
retention of atherogenic LDL is the initiating event of the
disease [39,40]. It is tempting to speculate that macro-
phages are present in the atherosclerotic intima because of
their antioxidant activity, which detoxifies and removes
cytotoxic products in the retained LDL.
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